RxDoctor Payments Data

Anay Patel, MD

Adult Reconstructive Orthopaedic Surgery · Houston, TXNPI 1588897011

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $181,987 of the $191,202 with a category attached, or 95.2%. Medical Device Business Services, Inc. accounts for 89.0% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $101,206, more than ten times the $3,682 reported in 2019.

$191,202in general payments, 2019–2025

Across 126 payments — averaging $1517.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$170K
  • Depuy Synthes Products, Inc.$19K
  • Johnson & Johnson$1K
  • Stryker$420
  • Spinal Elements, Inc.$116
  • Vertex$23
  • plus $12 from 1 others

What the payments were for

  • Consulting fees$181,98795%
  • Travel & lodging$6,6723%
  • Food & beverage$2,5431%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$191,202 in reported general payments places this provider in the 85th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$310,885
Medicare patients
416
Services billed
5,565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl316$2,991
Tranexamic Acid232$2,346
Doxycycline Hyclate303$2,123
Oxycodone Hcl322$1,523
Tramadol Hcl407$1,213
Meloxicam217$692
Methocarbamol41$366
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$231
Cephalexin51$68
Ondansetron OdtOndansetron11$64
Amoxicillin82$42

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →